| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 02/27/2013 | CN102210737B Sweet potato leaf extract and preparation method and use thereof |
| 02/27/2013 | CN102198091B Acupuncture point injection |
| 02/27/2013 | CN102138977B Baizhi Xiner decoction for adenoid vegetation |
| 02/27/2013 | CN101766608B Compound pseudoephedrine hydrochloride slow release preparation and preparing method thereof |
| 02/27/2013 | CN101759628B Ethynylindole compounds |
| 02/27/2013 | CN101757409B Application of traditional Chinese medicine composition in preparation of medicines for treating silicosis |
| 02/27/2013 | CN101687851B Organic compounds |
| 02/27/2013 | CN101683421B Applications of traditional Chinese medicine composition in preparation of medicament for treating repetitive respiratory tract infection |
| 02/26/2013 | US8383634 Methods of treatment using heteroaryl compounds and compositions thereof |
| 02/26/2013 | CA2674885C Anti-ige vaccines |
| 02/26/2013 | CA2674837C Anti-ige vaccines |
| 02/26/2013 | CA2551780C The combination of anticholinergics and glucocorticoids for the long-term treatment of asthma and copd |
| 02/26/2013 | CA2550848C Combination of anticholinergics and inhibitors of phosphodiesterase type 4 for the treatment of respiratory diseases |
| 02/26/2013 | CA2430115C Recombinant rsv virus expression systems and vaccines |
| 02/21/2013 | WO2013025733A1 Lysophosphatidic acid receptor antagonists |
| 02/21/2013 | WO2013025479A1 Jaml specific binding agents, antibodies, and uses related thereto |
| 02/21/2013 | WO2013024898A1 Heterocyclic derivative and pharmaceutical drug |
| 02/21/2013 | WO2013024427A1 Novel urea derivatives as tec kinase inhibitors and uses thereof |
| 02/21/2013 | WO2013024164A1 Combinations of a 5-ht4 receptor agonist and a pde4 inhibitor for use in therapy |
| 02/21/2013 | WO2013024052A1 Carrier-linked treprostinil prodrugs |
| 02/21/2013 | WO2013023882A1 Uridine and uridine analogues for treatment of specific lung diseases, namely copd and pulmonary fibrosis |
| 02/21/2013 | WO2013023856A1 Use of a polysaccharide polymer from the seeds of the tamarind seed in protecting against tobacco-associated damages |
| 02/21/2013 | WO2013023439A1 Salt and polymorph of pyrazolopyrimidinone compound and drug composition, preparation method and use thereof |
| 02/21/2013 | WO2012174028A3 Peptide compositions and methods for treating lung injury, asthma, anaphylaxis, angioedema, systemic vascular permeability syndromes, and nasal congestion |
| 02/21/2013 | US20130046275 Material and method for treating internal cavities |
| 02/21/2013 | US20130046240 Bepotastine compositions |
| 02/21/2013 | US20130046020 Eicosapentaenoic acid concentrate |
| 02/21/2013 | US20130046007 Selective reduction of allelic variants |
| 02/21/2013 | US20130046004 Oxygen-substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals |
| 02/21/2013 | US20130045997 Pirfenidone therapy and inducers of of cytochrome p450 |
| 02/21/2013 | US20130045988 Combination therapy |
| 02/21/2013 | US20130045973 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| 02/21/2013 | US20130045965 Inhibitors of bruton's tyrosine kinase |
| 02/21/2013 | US20130045964 Mandelamide heterocyclic compounds |
| 02/21/2013 | US20130045955 Novel compounds |
| 02/21/2013 | US20130045939 Fatty acid macrolide derivatives and their uses |
| 02/21/2013 | US20130045928 Uses of Natriuretic Peptide Constructs |
| 02/21/2013 | US20130045921 Therapeutic agent for rhinitis |
| 02/21/2013 | US20130045283 Compositions for and methods of controlling olfactory responses to odorants |
| 02/21/2013 | US20130045236 Diagnostic and therapeutic uses of soluble fc-epsilon receptor i for ige-mediated disorders |
| 02/21/2013 | US20130045169 Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity |
| 02/21/2013 | CA2845250A1 Salt and polymorph of pyrazolopyrimidinone compound, and pharmaceutical composition containing the same, preparation method and use thereof |
| 02/21/2013 | CA2845039A1 Combinations of a 5-ht4 receptor agonist and a pde4 inhibitor for use in therapy |
| 02/21/2013 | CA2844982A1 Lysophosphatidic acid receptor antagonists |
| 02/21/2013 | CA2844794A1 Heterocyclic derivative and pharmaceutical |
| 02/21/2013 | CA2843883A1 Carrier-linked treprostinil prodrugs |
| 02/20/2013 | EP2559706A1 Monoclonal antibodies that bind to hGM-CSF and medical compositions comprising same |
| 02/20/2013 | EP2559434A2 Treatment of COPD using a histidine decarboxylase inhibitor sole or combined with an anti-H1 drug or with a leucotriene receptor antagonist |
| 02/20/2013 | EP2558447A1 3-(heteroaryl-amino)-1,2,3,4-tetrahydro-9h-carbazole derivatives and their use as prostaglandin d2 receptor modulators |
| 02/20/2013 | EP2558113A2 Serca2 therapeutic compositions and methods of use |
| 02/20/2013 | EP2558097A1 Compound for treatment of respiratory condition or disease |
| 02/20/2013 | EP2557921A1 Methods for treatment of sleep-related breathing disorders |
| 02/20/2013 | CN102939303A Tetravalent cd47-antibody constant region fusion protein for use in therapy |
| 02/20/2013 | CN102939281A Process for the preparation of glycopyrronium chloride |
| 02/20/2013 | CN102939280A Crystal form of glycopyrronium chloride |
| 02/20/2013 | CN102939091A Pharmaceutical composition and use thereof in manufacturing medicaments for treating respiratory diseases |
| 02/20/2013 | CN102939087A Novel indazole derivative or salt thereof, manufacturing intermediate therefor, antioxidant using same, and use for an indazole derivative or salt thereof |
| 02/20/2013 | CN102936557A Liqueur capable of improving unhealthy symptom caused by smoking and preparation method of liqueur |
| 02/20/2013 | CN102935245A Wind-cold dispelling incense |
| 02/20/2013 | CN102935220A Medicine for improving sub-health condition of human body |
| 02/20/2013 | CN102935196A Cough-relieving and sputum-reducing tablets |
| 02/20/2013 | CN102935176A Buccal granules for chronic pharyngolaryngitis and preparation method |
| 02/20/2013 | CN102935149A Composition for treating livestock respiratory diseases and method for preparing composition |
| 02/20/2013 | CN102935143A Preparation method for compound traditional Chinese medicine preparation children common cold granules |
| 02/20/2013 | CN102935131A Application of Fructus Aurantii Immaturus total flavonoid extract in preparation of drug treating bronchial asthma |
| 02/20/2013 | CN102935113A Preparation method for Shuanghuanglian granules |
| 02/20/2013 | CN102935099A Extractive capable of reducing insulin resistance as well as preparation method and application thereof |
| 02/20/2013 | CN102935098A Acute turpinia leaf general flavone ethanol reflux extract, and preparation method and application thereof |
| 02/20/2013 | CN102344892B Chinese isolate of Leachiii mycoplasma, isolation culture medium and purpose thereof |
| 02/20/2013 | CN102293741B Bromhexine hydrochlorie injection, its preparation method and application |
| 02/20/2013 | CN101772489B Amine salts of a CRTH2 antagonist |
| 02/20/2013 | CN101541789B Hydantoin derivatives used as mmp inhibitors |
| 02/20/2013 | CN101496845B Hedyotis diffusa Willd. extract and method for separating and preparing the same |
| 02/20/2013 | CN101495110B Compositions and methods useful for treatment of respiratory illness |
| 02/20/2013 | CN101491601B Externally administrated preparation of superfine traditional Chinese medicine capable of increasing human disease resistance |
| 02/19/2013 | US8378099 Boronic ester and acid compounds, synthesis and uses |
| 02/19/2013 | US8377936 Nicotinic receptor agonists for the treatment of inflammatory diseases |
| 02/19/2013 | US8377893 Highly purified antiendotoxin compound |
| 02/19/2013 | CA2569716C Hydantoin derivatives for the treatment of obstructive airway diseases |
| 02/19/2013 | CA2486187C Kinase inhibitors |
| 02/14/2013 | WO2013021038A1 Bicyclic labdane diterpenes for use in the treatment of trpc6 associated diseases |
| 02/14/2013 | WO2013021021A1 Novel soft pde4 inhibitors |
| 02/14/2013 | WO2013020993A1 Compounds for the treatment and prophylaxis of respiratory syncytial virus disease |
| 02/14/2013 | WO2013020164A1 Compounds for treating respiratory syncytial virus infections |
| 02/14/2013 | WO2012097238A3 Il-27 antagonists for treating inflammatory diseases |
| 02/14/2013 | US20130041026 Anhydrous and hemihydrate crystalline forms of an (r)-baclofen prodrug, methods of synthesis and methods of use |
| 02/14/2013 | US20130041006 Pharmaceutical composition for intracellar acidification with cis-urocanic acid |
| 02/14/2013 | US20130041005 Pharmaceutical compositions comprising neuropilin inhibitors, and their use for the prevention and/or treatment of angiogenic disorders and cancers |
| 02/14/2013 | US20130041000 Novel azole compound |
| 02/14/2013 | US20130040997 Novel pyridine carboxylic acid based compound used as a p2x1 and p2x3 receptor antagonist, a production method for the same and a composition comprising the same |
| 02/14/2013 | US20130040995 Novel compounds |
| 02/14/2013 | US20130040994 Methods of Treatment Using Allosteric Processing Inhibitors for Matrix Metalloproteinases |
| 02/14/2013 | US20130040986 Modulators of Cystic Fibrosis Transmembrane Conductance Regulator |
| 02/14/2013 | US20130040974 Piperidine inhibitors of janus kinase 3 |
| 02/14/2013 | US20130040971 6-cycloalkyl-pyrazolopyrimidinones for the treatment of cns disorders |
| 02/14/2013 | US20130040962 P38 MAP Kinase Inhibitors |
| 02/14/2013 | US20130040957 Deuterium-Enriched Pyrimidine Compounds and Derivatives |
| 02/14/2013 | US20130040940 Mercaptoamidine derivatives and methods of use |
| 02/14/2013 | US20130040933 Azaindoles as janus kinase inhibitors |
| 02/14/2013 | US20130040926 Novel compound |